                         SEQUENCE LISTING

<110>  Beth Israel Deaconess Medical Center, Inc.
 
<120>  COMPOSITIONS AND METHODS FOR EVALUATION OF ANTIPLATELET DRUG 
       SENSITIVITY

<130>  B0662.70103WO00

<140>  Not Yet Assigned
<141>  Concurrently Herewith

<150>  US 62/722,378
<151>  2018-08-24

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  1

Ser Phe Leu Leu Arg Asn 
1               5       


<210>  2
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  2

Ala Tyr Pro Gly Lys Phe 
1               5       


<210>  3
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  Xaa is pyrrolysine

<400>  3

Leu Ile Gly Arg Leu Xaa 
1               5       


<210>  4
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  4

Leu Arg Gly Ile Leu Ser 
1               5       


<210>  5
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  5

Thr Phe Leu Leu Arg 
1               5   


